<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02431845</url>
  </required_header>
  <id_info>
    <org_study_id>4-2010-0577</org_study_id>
    <nct_id>NCT02431845</nct_id>
  </id_info>
  <brief_title>Pharmacogenetic Study of Obsessive-Compulsive Disorder</brief_title>
  <official_title>Pharmacogenetic Study of Obsessive-Compulsive Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Severance Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Severance Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether pharmacogenetic study predict selective
      serotonin reuptake inhibitor (SSRI) responsiveness in advance before the appearance of the
      drug effect until 4 months(16 weeks), 6 months, and 1 year after administration of SSRIs.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to determine the effects of genetic variants on the response to
      SSRIs in obsessive-compulsive disorder (OCD) subject.

      The investigators will recruit drug-naive or drug-free(&gt; 3 months) OCD subjects (n=200). The
      participants will get SSRIs for their OCD symptoms. The type and dose of SSRIs will not be
      restricted and will depend on the individual participant's state. However, the investigators
      will be recommended to follow usual clinical guideline (the Korean treatment algorithm for
      OCD, 2004). At baseline, 4 month, 6 months, and 1 year after treatment, the participants will
      be evaluated by Yale-Brown Obsessive-Compulsive Scale(YBOCS), Montgomery Asberg Depression
      Rating Scale(MADRS), Dimensional Obsessive-Compulsive Scale(DOCS), Toronto alexithymia scale
      (TAS), interpersonal reactivity index (IRI), Barratt impulsiveness scale (BIS), and the
      Measure of Constructs Underlying Perfectionism(M-CUP).

      And all the participants will donate 5 ml of whole blood and DNA will be extracted.

      Using various genetic analyses methods such as genotyping, exome sequencing, and so on we
      will analyze the association of various genetic variants and the anti-obsessive-compulsive
      responses.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Open naturalistic treatment</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>Open label study</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in the Yale-Brown Obsessive-Compulsive Scale</measure>
    <time_frame>baseline, 4 months, 6 months, 1 year</time_frame>
    <description>rating scale for obsessive-compulsive symptom severity consisting of 10 items</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from the baseline Montgomery-Asberg Depression Rating Scale</measure>
    <time_frame>baseline, 4 months, 6 months, 1 year</time_frame>
    <description>rating scale for depressive symptom severity consisting of 10 items</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of any side effects during the SSRIs treatment</measure>
    <time_frame>4 months, 6 months, 1 year</time_frame>
    <description>any adverse events related to SSRI use</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Obsessive-Compulsive Disorder</condition>
  <arm_group>
    <arm_group_label>SSRIs treatment as usual OCD gruop</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>SSRIs treatment as usual fluoxetine 40~80 mg dose equivalent (fluoxetine, paroxetine, sertraline, fluvoxamine, escitalopram, clomipramine)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>SSRIs</intervention_name>
    <description>usual dose SSRI for obsessive-compulsive disorder, i.e. fluoxetine 40~80 mg dose equivalents</description>
    <arm_group_label>SSRIs treatment as usual OCD gruop</arm_group_label>
    <other_name>five kinds of SSRIs including fluoxetine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. age 19~ 60

          2. OCD by Diagnostic and Statistical Manual for Mental disorders, 4th edition (DSM-IV)

          3. drug naive or drug free for more than 3 months

        Exclusion Criteria:

          1. any neurological disorder

          2. comorbid psychotic disorders

          3. alcohol or other substance dependence within past 6 months

          4. any evidences for brain diseases
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Se Joo Kim, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Professor, Department of Psychiactry, Yonsei Univ. College of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Se Joo Kim, M.D.</last_name>
    <phone>+82-2-2228-1627</phone>
    <email>kimsejoo@yuhs.ac</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jee In Kang, M.D.</last_name>
    <phone>+82-2-2228-1630</phone>
    <email>jeeinkang@yuhs.ac</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Yonsei Univ. Health System Severance Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>120-752</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Se Joo Kim, M.D.</last_name>
      <phone>+82-2-2228-1620</phone>
      <email>kimsejoo@yuhs.ac</email>
    </contact>
    <contact_backup>
      <last_name>Jee In Kang, M.D.</last_name>
      <phone>+82-2-2228-1620</phone>
      <email>kji0354@yahoo.co.kr</email>
    </contact_backup>
    <investigator>
      <last_name>Se Joo Kim, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jee In Kang, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 23, 2015</study_first_submitted>
  <study_first_submitted_qc>April 27, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 1, 2015</study_first_posted>
  <last_update_submitted>April 24, 2017</last_update_submitted>
  <last_update_submitted_qc>April 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Severance Hospital</investigator_affiliation>
    <investigator_full_name>Se Joo Kim</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Obsessive-Compulsive Disorder</keyword>
  <keyword>Pharmacogenetics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Compulsive Personality Disorder</mesh_term>
    <mesh_term>Obsessive-Compulsive Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fluoxetine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

